EA201301061A1 - Фармацевтическая композиция, содержащая инозит - Google Patents

Фармацевтическая композиция, содержащая инозит

Info

Publication number
EA201301061A1
EA201301061A1 EA201301061A EA201301061A EA201301061A1 EA 201301061 A1 EA201301061 A1 EA 201301061A1 EA 201301061 A EA201301061 A EA 201301061A EA 201301061 A EA201301061 A EA 201301061A EA 201301061 A1 EA201301061 A1 EA 201301061A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
composition containing
inositis
inositol
isomer
Prior art date
Application number
EA201301061A
Other languages
English (en)
Other versions
EA026746B1 (ru
Inventor
Витторио Унфер
Original Assignee
Ло.Ли. Фарма С.Р.Л.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ло.Ли. Фарма С.Р.Л. filed Critical Ло.Ли. Фарма С.Р.Л.
Publication of EA201301061A1 publication Critical patent/EA201301061A1/ru
Publication of EA026746B1 publication Critical patent/EA026746B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к фармацевтической композиции, содержащей растворы, суспензии или дисперсии инозита или его изомера в основе, содержащей желатин, глицерин или смесь из них.
EA201301061A 2011-03-22 2012-03-21 Фармацевтическая композиция, содержащая инозит EA026746B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000445A ITMI20110445A1 (it) 2011-03-22 2011-03-22 Formulazione farmaceutica comprendente inositolo.
PCT/EP2012/054960 WO2012126931A1 (en) 2011-03-22 2012-03-21 Pharmaceutical formulation comprising inositol

Publications (2)

Publication Number Publication Date
EA201301061A1 true EA201301061A1 (ru) 2014-02-28
EA026746B1 EA026746B1 (ru) 2017-05-31

Family

ID=43977111

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201301061A EA026746B1 (ru) 2011-03-22 2012-03-21 Фармацевтическая композиция, содержащая инозит

Country Status (22)

Country Link
US (1) US20140010870A1 (ru)
EP (2) EP2502622B1 (ru)
CL (1) CL2013002700A1 (ru)
CY (2) CY1122980T1 (ru)
DK (2) DK3178474T3 (ru)
EA (1) EA026746B1 (ru)
ES (2) ES2806937T3 (ru)
HR (2) HRP20200792T1 (ru)
HU (2) HUE049942T2 (ru)
IL (1) IL228465B (ru)
IT (1) ITMI20110445A1 (ru)
LT (2) LT3178474T (ru)
MA (1) MA35043B1 (ru)
ME (1) ME03750B (ru)
MX (1) MX2013010812A (ru)
PE (1) PE20141011A1 (ru)
PL (2) PL3178474T3 (ru)
PT (2) PT3178474T (ru)
RS (2) RS60650B1 (ru)
TN (1) TN2013000373A1 (ru)
UA (1) UA115425C2 (ru)
WO (1) WO2012126931A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUA20163025A1 (it) 2016-04-29 2017-10-29 Sochim Int S P A Composizione per il trattamento della sindrome dell’ovaio policistico
JP6838146B2 (ja) * 2016-10-06 2021-03-03 ディーワイ ナチュラル カンパニー リミテッド ピニトール、ｄ−カイロ−イノシトール、又はこれらの類似化合物を有効成分として含む、女性の更年期症状の改善、予防、又は治療用の組成物
US11898184B2 (en) * 2017-09-07 2024-02-13 Sweet Sense Inc. Low glycemic sugar composition
BR112020010343A2 (pt) 2017-11-23 2020-11-10 Biosearch, S.A. método para aumentar taxa de implantação de embrião em um paciente feminino sofrendo de síndrome de ovário policístico
US20210236528A1 (en) * 2018-08-22 2021-08-05 Societe Des Produits Nestle S.A. Composition comprising isomers of inositol and its use
JP2022546267A (ja) * 2019-08-30 2022-11-04 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ｓｃｙｌｌｏ－イノシトール及びβ細胞介在性疾患
CN115484939A (zh) * 2019-09-24 2022-12-16 雀巢产品有限公司 鲨肌醇及其作为胰岛素敏化剂的用途
RU2757220C1 (ru) * 2020-06-03 2021-10-12 Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" Фармацевтическая композиция для профилактики и лечения синдрома поликистозных яичников
RU2771426C1 (ru) * 2021-05-03 2022-05-04 Румиса Рамзановна Бериханова Способ коррекции дислипидемии у женщин с метаболическим синдромом в периоде менопаузального перехода

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8305693D0 (en) * 1983-03-02 1983-04-07 Scherer Ltd R P Pharmaceutical compositions
AU647735B2 (en) * 1989-03-08 1994-03-31 University Of Virginia Alumni Patents Foundation, The Dietary supplement for insulin-resistant diabetics
TW282398B (ru) * 1993-12-22 1996-08-01 Bristol Myers Squibb Co
WO2000064454A2 (en) * 1999-04-27 2000-11-02 Insmed Pharmaceuticals, Inc. Pharmaceutical composition comprising an inositol and a metal ion for improving insulin sensitivity and glucose metabolism
DK1274459T3 (da) * 2000-04-19 2006-02-06 Genentech Inc Præparater med vedholdende frigivelse indeholdende væksthormon
WO2006011592A1 (ja) * 2004-07-30 2006-02-02 Wakunaga Pharmaceutical Co., Ltd. カプセル皮膜用組成物、カプセル皮膜、及びこれを用いたカプセル剤
JP5088873B2 (ja) * 2005-07-04 2012-12-05 国立大学法人 東京医科歯科大学 Ｌ−アルギニン含有医薬組成物及び飲食品用組成物
JP2009514965A (ja) * 2005-11-07 2009-04-09 ペーク，エルエルシー 代謝障害を制御するための組成物およびその使用方法
US20070104801A1 (en) * 2005-11-07 2007-05-10 Ivf Online Llc Fertility and anti-aging supplement for the fertility health of females and males
ITRM20070341A1 (it) * 2007-06-20 2008-12-21 Lo Li Pharma Srl Formulazione integrativa inofolic finalizzata al controllo dell'induzione dell'ovulazione in programmi di procreazione medicalmente assistita
US20120232003A1 (en) * 2009-03-13 2012-09-13 Takahashi Joseph S Compositions and methods for diabetes treatment
EP2542224B1 (en) * 2010-03-01 2014-08-13 Ratiopharm GmbH Dabigatran etexilate-containing oral pharmaceutical composition

Also Published As

Publication number Publication date
CY1123134T1 (el) 2021-10-29
PL3178474T3 (pl) 2020-09-21
PL2502622T3 (pl) 2020-11-16
WO2012126931A1 (en) 2012-09-27
UA115425C2 (uk) 2017-11-10
DK2502622T3 (da) 2020-09-07
EP2502622B1 (en) 2020-06-10
CY1122980T1 (el) 2021-10-29
EP3178474B1 (en) 2020-03-18
ES2806937T3 (es) 2021-02-19
LT3178474T (lt) 2020-05-11
HUE051001T2 (hu) 2021-01-28
DK3178474T3 (da) 2020-06-08
HRP20200792T1 (hr) 2020-07-24
CL2013002700A1 (es) 2014-07-11
RS60377B1 (sr) 2020-07-31
ITMI20110445A1 (it) 2012-09-23
IL228465B (en) 2018-01-31
EA026746B1 (ru) 2017-05-31
LT2502622T (lt) 2020-07-27
PT3178474T (pt) 2020-05-06
ME03750B (me) 2021-04-20
MX2013010812A (es) 2014-03-21
EP2502622A1 (en) 2012-09-26
MA35043B1 (fr) 2014-04-03
RS60650B1 (sr) 2020-09-30
TN2013000373A1 (en) 2015-01-20
EP3178474A1 (en) 2017-06-14
HUE049942T2 (hu) 2020-11-30
PE20141011A1 (es) 2014-08-27
ES2798267T3 (es) 2020-12-10
HRP20201048T1 (hr) 2020-10-16
PT2502622T (pt) 2020-06-29
IL228465A0 (en) 2013-12-31
US20140010870A1 (en) 2014-01-09

Similar Documents

Publication Publication Date Title
EA201301061A1 (ru) Фармацевтическая композиция, содержащая инозит
PH12016501151A1 (en) Nrf2 regulators
EA202092987A2 (ru) Липид, содержащий докозапентаеновую кислоту
EA201400833A1 (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
EA201591748A1 (ru) Модуляторы p2x7
IN2015DN03029A (ru)
EA201590731A1 (ru) Антитела к гемагглютинину и способы применения
BR112013028512A2 (pt) cápsula
UA109931C2 (xx) Піримідинциклогексильні модулятори глюкокортикоїдних рецепторів
UY34779A (es) Anticuerpos anti-il-23 y composiciones farmacéuticas que los contienen
MY168300A (en) Pharmaceutical Composition for Inhalation
UY33906A (es) Composiciones herbicidas que comprenden topramezona
EA201600124A1 (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
EA201490037A1 (ru) Антагонисты trpv4
UY4281Q (es) Juguera
EA201591451A1 (ru) Модуляторы flap
TR201821285T4 (tr) CCR3 antagonisti içeren farmasötik formülasyonlar.
UA116889C2 (uk) Фармацевтична композиція, що містить суміш ізоформ apg101 (cd95-fc)
UY34158A (es) Composicion herbicida
UY34166A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
UY36292A (es) Compuestos de tetrahidroquinolina para su uso como inhibidores de bromodominios
UA113540C2 (xx) Поліморфи n-(2-метоксибензоїл)-4-$(метиламінокарбоніл)аміно]бензолсульфонаміду
CY1119871T1 (el) Στερεη μορφη αλατος της aλφa-6-mpeg6-o- υδροξυκωδονης ως αγωνιστες οπιοειδων και χρησεις αυτων
UY34595A (es) Composición farmacéutica de liberación prolongada de trimetazidina
BR112013029778A2 (pt) composição farmacêutica que compreende fexofenadina

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY KG MD TJ TM